1. Home
  2. Analysis

Encephalitis viral and drugs of ingredients of sirolimus (a real world drug study)


Summary:

Encephalitis viral is found among people who take drugs with ingredients of sirolimus, especially for people who are male, 60+ old . This phase IV clinical study is created by eHealthMe based on reports of 25,405 people who have side effects when taking drugs with ingredients of sirolimus from the FDA, and is updated regularly.

Drug(s) considered in the study (i.e. both brand name and generic drugs): Fyarro, Hyftor, Rapamune, Sirolimus.

On Jul, 28, 2026

25,405 people reported to have side effects when taking drugs with ingredients of sirolimus.
Among them, 15 people (0.06%) have Encephalitis viral

What is Encephalitis viral?

Encephalitis viral (inflammation of the brain due to viral infection) is found to be associated with 147 drugs and 307 conditions by eHealthMe. Check the latest studies of Encephalitis viral.

Number of reports submitted per year:

Could drugs with ingredients of sirolimus cause Encephalitis viral?

Gender of people who have Encephalitis viral when taking drugs with ingredients of sirolimus *:

  • female: 33.33 %
  • male: 66.67 %

Age of people who have Encephalitis viral when taking drugs with ingredients of sirolimus *:

  • 0-1: 0.0 %
  • 2-9: 25 %
  • 10-19: 25 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 25 %
  • 60+: 25 %

Conditions people have *:

You may use this to check any potential undetected conditions.

  1. Immunodeficiency Disorders: 4 people, 26.67%
  2. Autoimmune Hepatitis: 3 people, 20.00%
  3. Cutaneous Vasculitis (an inflammatory process affecting the vessel wall that leads to its damage): 2 people, 13.33%
  4. Polyomavirus-Associated Nephropathy (polyomavirus-associated kidney disease): 1 person, 6.67%
  5. Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 1 person, 6.67%
  6. Epstein-Barr Virus Associated Lymphoproliferative Disorder (lymphocytes are produced in excessive quantities associated with epstein-barr virus): 1 person, 6.67%
  7. Epstein-Barr Viraemia: 1 person, 6.67%
  8. Bk Virus Infection: 1 person, 6.67%

Other drugs people take *:

You may use this to check any potential interacting drugs.

  1. Prednisone: 4 people, 26.67%
  2. Mycophenolate Mofetil: 4 people, 26.67%
  3. Cyclophosphamide: 4 people, 26.67%
  4. Cyclosporine: 3 people, 20.00%
  5. Thiotepa: 2 people, 13.33%
  6. Folic Acid: 2 people, 13.33%
  7. Atenolol: 2 people, 13.33%
  8. Acyclovir: 2 people, 13.33%
  9. Vistide: 1 person, 6.67%
  10. Vincristine Sulfate: 1 person, 6.67%

Other side effects people have besides Encephalitis viral *:

You may use this to check any potential undetected side effects.

  1. Acute Graft Versus Host Disease (acute complication following an allogeneic tissue/blood transplant): 3 people, 20.00%
  2. Bacterial Infection: 3 people, 20.00%
  3. Bk Virus Infection: 3 people, 20.00%
  4. Human Herpesvirus 6 Infection: 3 people, 20.00%
  5. Epstein-Barr Viraemia: 3 people, 20.00%
  6. Viral Haemorrhagic Cystitis (lower urinary tract symptoms that include haematuria and irritative voiding symptoms): 2 people, 13.33%
  7. Ecchymosis (a discoloration of the skin resulting from bleeding underneath): 2 people, 13.33%
  8. Lymphadenitis (inflammation or enlargement of a lymph node): 2 people, 13.33%
  9. Kidney Transplant Rejection: 2 people, 13.33%
  10. Haemolytic Uraemic Syndrome (blood clotting disease caused by e. coli infection, birth control pills, pneumonia, medications, and more): 2 people, 13.33%

* Approximation only. Some reports may have incomplete information.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Drugs with ingredients of sirolimus, their effectiveness, alternatives and more:

How the study uses the data?

The study uses data from the FDA. It is based on sirolimus. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.